Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 3/20 | 0.35 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23893541 | 0.90 | P2RY12 (0.36) | CTSKCALCRLITGB3ITGA2BHPGD | |
| SCHEMBL14580885 | 0.90 | CTSK (0.38) | CTSKCALCRLITGB3ITGA2BHPGD | |
| SCHEMBL7298353 | 0.86 | CYP2D6 (0.46) | CTSKCALCRLITGB3ITGA2BCYP2D6 | |
| SCHEMBL23879097 | 0.83 | HPGD (0.38) | CTSKITGB3ITGA2BHPGDCYP2D6 | |
| SCHEMBL24822362 | 0.83 | HPGD (0.38) | CTSKITGB3ITGA2BHPGDCYP2D6 | |
| SCHEMBL26013230 | 0.82 | HPGD (0.38) | CTSKITGB3ITGA2BHPGDCYP2D6 | |
| SCHEMBL26010069 | 0.79 | CTSK (0.41) | CTSKCALCRLITGB3ITGA2BCYP2D6 | |
| SCHEMBL12989824 | 0.79 | CCKBR (0.41) | P2RY12 | |
| SCHEMBL12989653 | 0.79 | CCKBR (0.41) | P2RY12 | |
| SCHEMBL25186364 | 0.76 | ITGB3 (0.54) | CTSKCALCRLITGB3ITGA2BCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8501498-B2 | Mass tags for quantitative analyses | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-08-06 | — | — | US | disclosed |
| US-20100311175-A1 | MASS TAGS FOR QUANTITATIVE ANALYSES | Life Technologies Corporation (US) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311175-A1 | MASS TAGS FOR QUANTITATIVE ANALYSES | SRMS, PTMS, TMT1A | CTSK 1970/4885CALCRL 3162/4885ITGB3 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.